Debates in EC Management: How to choose First-line therapy for your metastatic EC patient

New ESGO Live Webinar:

Debates in EC Management:

How to choose First-Line therarapy for your metastatic EC patient

Friday, November 29th, 2024 | 14:00 CEST (Time zone conversions)

Chairs: Alexandra Leary, France & AnnaMaria Fererro, Italy

Get ready to join the special live multidisciplinary tumour board webinar with world-leading experts from Europe, Asia–Pacific, Latin America, and the Middle East for a practical discussion on the latest updates in endometrial cancer management.

The webinar is an educational initiative designed mainly for ESGO's non-European members, with panellists from these countries at times that are convenient for them.

In this 90-minute live webinar, Professors Nicole Concin and Domenica Lorusso will discuss with the panellists a selection of real-life clinical cases related to endometrial cancer surgery, adjuvant and systematic treatment, and more.

The webinar will include:
+ Short Presentations of Clinical Cases
pre-selected by the tumour board panel.
+ Panel Discussion and Q&A
After each case, participants will be able to send questions to the panel during the webinar.
+ Practical Tips and Recommendations
Related to the presented cases and discussion topics.

Explore the video from the webinar chairs to find out more!

Watch Video

Webinar Topics

The webinar aims to share expertise derived from clinical experiences across the globe, promote best practices in gynaecological oncology, and improve the quality of treatment.

Key Discussion Topics include:
+ FIGO Staging and molecular profiling
+ Surgical staging of EC, including sentinel lymph nodes
+ Adjuvant setting according to risk stratification
+ Treatment of advanced and metastatic disease
+ New biomarker in EC
and more.

Agenda for November 29th, 2024

Meet the Webinar Experts Panel

Webinar Co-Chairs:

Prof. Nicole ConcinProf. Nicole Concin

Medical University of Vienna, Austria

“These are exciting times for us as physicians and particularly for our patients with endometrial cancer, as tremendous advancements are being made that allow us to offer more effective and individualised treatment options. The basis for these advancements is a better understanding of tumour biology and access to molecular characterisation.
Endometrial cancer is not one single disease; it constitutes at least four molecularly defined different diseases. This holds immediate clinical relevance for an improved estimate of a patient's prognosis and for adjuvant and systematic treatment decision-making.
We look forward to seeing you at our webinar and discussing clinically relevant cases with you!"
Prof. Concin, ESGO Past President

Prof. Domenica Lorusso

Catholic University of Rome
Fondazione Policlinico Gemelli IRCCS, Rome, Italy

“We are living in an unprecedented moment in the treatment and clinical research of endometrial cancer. The biological knowledge of the disease has a direct influence on prognosis and treatment opportunities in surgery, adjuvant settings, and the treatment of advanced disease.
Join us for an exciting live discussion with a panel of distinguished experts focused on clinical cases of endometrial cancer. See you all online!"
Prof. Lorusso, ESGO Council Member